Abstract:Efficient delivery of pharmaceutically active molecules across cellular membranes using cell penetrating peptides (CPPs), such as the cationic human immunodeficiency virus-1 trans-acting activator of transcription peptide (HIV-1 TAT), continues to attract scientific attention in drug design and disease treatment. Experimental results show that the TAT peptide is not only capable of directly penetrating the biological membrane in a passive manner, but also forming physical, membrane-spanning pores that may facilitate transport. Experiments further show that anionic lipids accelerate peptide permeation within a range of mole percentage composition. In this work, we explored the structures and translocation thermodynamics of the cationic TAT peptide across a series of DPPC/DPPS model membranes with the presence of 0-30 mol% cholesterol. We computed the potentials of the mean force by using umbrella sampling molecular dynamics simulations coupled to the Martini coarse-grained force field. We systematically investigated the roles of cholesterol and anionic lipids (membrane surface charge) in TAT peptide translocation. In qualitative agreement with experimental findings, the barrier heights were significantly reduced in the presence of anionic lipids. A toroidal hydrophilic pore was strongly suggested by membrane structure analysis. Cholesterol stabilizes the liquid-ordered (Lo) phase of membranes and increases the elastic stiffness of bilayers. Consequently, it hinders transmembrane pore formation and thus modulates solute permeability, since the liquid-ordered phase suppresses reorientation of the lipid molecules on simulation time scales. Though cholesterol contributes marginally to the total free energy associated with peptide permeation, the coordination of cholesterol to the peptide weakens more favorable peptide-lipid interactions. The addition of the anionic lipid DPPS to the neutral DPPC bilayer leads to the emergence and further enhancement of an interfacially stable state of the peptide due to the favorable peptide-anionic lipid interactions. Translocation free energy barriers decrease in lockstep with increasing DPPS composition in the model bilayers simulated. Finally, we investigated the size of hydrophilic pores emerging in our simulations, as well as the qualitative mobility of the peptide on the membrane surface.

HIV-1 Tat membrane interactions probed using X-ray and neutron scattering, CD spectroscopy and MD simulations.

Penetration of Hiv-1 Tat(47-57) into Pc/Pe Bilayers Assessed by Md Simulation and X-Ray Scattering

Insertion of TAT Peptide and Perturbation of Negatively Charged Model Phospholipid Bilayer Revealed by Neutron Diffraction.

Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA

Frozen translational and rotational motion of human immunodeficiency virus transacting activator of transcription peptide-modified nanocargo on neutral lipid bilayer.

Molecular Mechanism of HIV-1 TAT Peptide and Its Conjugated Gold Nanoparticles Translocating Across Lipid Membranes

Thermodynamics of cell-penetrating HIV1 TAT peptide insertion into PC/PS/CHOL model bilayers through transmembrane pores: the roles of cholesterol and anionic lipids

Probing Interaction of a Fluorescent Ligand with HIV TAR RNA.

Interaction of the Second Coding Exon of Tat with Human Ef-1 Delta Delineates A Mechanism for Hiv-1-Mediated Shut-Off of Host Mrna Translation

Identification and Nanomechanical Characterization of the HIV Tat-Amyloid Peptide Multifibrillar Structures

Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding

Folding molecular dynamics simulation of T-peptide, a HIV viral entry inhibitor : Structure, dynamics, and comparison with the experimental data

Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture

Structural Basis for TatA Oligomerization: an NMR Study of Escherichia Coli TatA Dimeric Structure.

Enzyme Hinders HIV-1 Tat Viral Transport and Real-Time Measured with Nanopores

Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors

Combined Metabonomic and Quantitative Real-Time Pcr Analyses Reveal Systems Metabolic Changes in Jurkat T-Cells Treated with Hiv-1 Tat Protein

New insights into the Tat protein transport cycle from characterizing the assembled Tat translocon

Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell penetrating peptides

Modulation of the Stability and Activities of HIV-1 Tat by Its Ubiquitination and Carboxyl-Terminal Region.

Efficient Internalization of TAT Peptide in Zwitterionic DOPC Phospholipid Membrane Revealed by Neutron Diffraction